During the diagnosis of IIM, autoantibodies are deemed dependable for distinguishing various myopathy subtypes, primarily divided into myositis-specific autoantibodies (MSA) and myositis-associated autoantibodies (MAA) (153). This evidence concerns the gene NAA10 and myositis disease.